- Home
- CLDI vs GIGM Comparison
CLDI vs GIGM Comparison
Compare CLDI & GIGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- GIGM
- Stock Information
- Founded
- CLDI 2014
- GIGM 1998
- Country
- CLDI United States
- GIGM Taiwan
- Employees
- CLDI N/A
- GIGM N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- GIGM Computer Software: Programming Data Processing
- Sector
- CLDI Health Care
- GIGM Technology
- Exchange
- CLDI Nasdaq
- GIGM Nasdaq
- Market Cap
- CLDI 15.7M
- GIGM 17.9M
- IPO Year
- CLDI N/A
- GIGM 2000
- Fundamental
- Price
- CLDI $0.40
- GIGM $1.44
- Analyst Decision
- CLDI Strong Buy
- GIGM
- Analyst Count
- CLDI 2
- GIGM 0
- Target Price
- CLDI $15.00
- GIGM N/A
- AVG Volume (30 Days)
- CLDI 202.0K
- GIGM 11.8K
- Earning Date
- CLDI 05-20-2025
- GIGM 05-05-2025
- Dividend Yield
- CLDI N/A
- GIGM N/A
- EPS Growth
- CLDI N/A
- GIGM N/A
- EPS
- CLDI N/A
- GIGM N/A
- Revenue
- CLDI N/A
- GIGM $3,103,000.00
- Revenue This Year
- CLDI N/A
- GIGM N/A
- Revenue Next Year
- CLDI N/A
- GIGM N/A
- P/E Ratio
- CLDI N/A
- GIGM N/A
- Revenue Growth
- CLDI N/A
- GIGM N/A
- 52 Week Low
- CLDI $0.35
- GIGM $1.26
- 52 Week High
- CLDI $4.90
- GIGM $1.80
- Technical
- Relative Strength Index (RSI)
- CLDI 36.62
- GIGM 33.95
- Support Level
- CLDI $0.40
- GIGM $1.43
- Resistance Level
- CLDI $0.46
- GIGM $1.50
- Average True Range (ATR)
- CLDI 0.04
- GIGM 0.04
- MACD
- CLDI 0.00
- GIGM -0.01
- Stochastic Oscillator
- CLDI 9.73
- GIGM 5.89
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About GIGM GigaMedia Limited
GigaMedia Ltd is a publisher of online games. It has only one reportable segment, Digital Entertainment service. Digital Entertainment service business operates a portfolio of online games, mainly targeting online game players across Europe, and Asia, including Greater China and Southeast Asia. The company's portfolio of online games includes predominantly PC-based, non-cash gambling, or casino casual games, including MahJong and various card and table games. The company's product lines include MahJong, AkaSeka, Yume 100, Fun Vegas, and others. The company operates in Taiwan and Hong Kong.